載入...
Islet Hormone and Incretin Secretion in Cystic Fibrosis after Four Months of Ivacaftor Therapy
Rationale: Diabetes is associated with worse cystic fibrosis (CF) outcomes. The CFTR potentiator ivacaftor is suggested to improve glucose homeostasis in individuals with CF. Objectives: To test the hypothesis that clinically indicated ivacaftor would be associated with improvements in glucose toler...
Na minha lista:
| 發表在: | Am J Respir Crit Care Med |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Thoracic Society
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6835076/ https://ncbi.nlm.nih.gov/pubmed/30130412 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201806-1018OC |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|